• Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Titan Pharmaceuticals Inc

+ Add to Watchlist

TTNP:US

0.4800 USD 0.0200 4.35%

As of 20:10:04 ET on 11/26/2014.

Snapshot for Titan Pharmaceuticals Inc (TTNP)

Open: 0.4550 Day's Range: 0.4550 - 0.4880 Volume: 278,551
Previous Close: 0.4600 52wk Range: 0.4400 - 0.8999 1-Yr Rtn: -37.50%

Stock Chart for TTNP

No chart data available.
  • TTNP:US 0.4780
  • 1D
  • 1M
  • 1Y
0.4600
Interactive TTNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0400
Est. EPS (USD) (12/2014) -0.0300
Est. PEG Ratio -
Market Cap (M USD) 52.80
Shares Outstanding (M) 110.00
30 Day Average Volume 184,857
Price/Book (mrq) 12.4206
Price/Sale (ttm) 11.5843
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TTNP

Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. The company is also developing gene therapy and drug delivery technologies.

Marc RubinChairmanSunil BhonslePresident/CFO
Katherine Glassman-BeebeExec VP/Chief Development Officer
More Company Profile & Key Executives for TTNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil